ECCO 14: As global cancer estimates soar, Europe moves to decriminalise MRI (magnetic resonance imaging)
This article was originally published in Clinica
Top medical technology and high clinical need meet major regulatory damage. This is how the Federation of European Cancer Societies (FECS) - now the European CanCer Organisation (ECCO) - sees the legal barriers being erected around technologies such as magnetic resonance imaging (MRI) and stem cells, in the face of a burgeoning demand.
You may also be interested in...
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.
Butterfly Network’s CEO Laurent Faracci outlines the company’s growth strategy and plans for their “ultrasound-on-a-chip” technology after its merger with blank check company Longview Acquisition Corp. See what the company’s CEO said about it here.
CDC’s Advisory Committee on Immunization Practices votes 13-1 that these two groups be first in line for vaccination once FDA authorizes a vaccine and ACIP recommends it. Goal of vote is to guide health departments in placing vaccine orders.